Literature DB >> 19128819

Gleason grading of prostatic adenocarcinoma with glomeruloid features on needle biopsy.

Tamara L Lotan1, Jonathan I Epstein.   

Abstract

Glomerulations in prostatic adenocarcinoma are characterized by dilated glands containing intraluminal cribriform structures with a single point of attachment, resembling a renal glomerulus. On prostate biopsy, glomerulations are exclusively associated with carcinoma and not associated with benign mimickers. However, the Gleason grading of carcinoma with glomerulations on needle biopsy remains controversial. We prospectively collected 45 prostate needle biopsies containing carcinoma with glomeruloid features from our consult files for a 9-month period and examined the association between glomerulations and the presence of concurrent high-grade carcinoma. Glomerulations were overwhelmingly associated with high-grade cancer on the same core, composed of either Gleason pattern 4 (n = 36, 80% of cases) or Gleason pattern 5 (n = 2, 4% of cases). Only a minority of glomerulations were surrounded exclusively by pattern 3 cancer (n = 7, 16% of cases) on the same core. Most of the cases with surrounding pattern 4 cancer were scored as 3 + 4 = 7 (n = 24, 66%), whereas a smaller fraction were scored as 4 + 3 = 7 (n = 9, 26%), and only a minority were 4 + 4 = 8 (n = 3, 9%). In most cases, glomeruloid change was present on the same core as the highest Gleason score carcinoma of the case. None of the pattern 3 cases and only a minority of the pattern 4 cancers had higher Gleason score carcinoma on additional cores (n = 5, 14%). Glomeruloid structures are a rare but diagnostic feature of prostatic carcinoma on needle biopsy. Our data indicate that glomerulations are overwhelmingly associated with concurrent Gleason pattern 4 or higher-grade carcinoma. In several cases, transition could be seen among small glomerulations, large glomeruloid structures, and cribriform pattern 4 cancer. These data suggest that glomerulations represent an early stage of cribriform pattern 4 cancer and, until follow-up data are available, are best graded as Gleason pattern 4.

Entities:  

Mesh:

Year:  2009        PMID: 19128819      PMCID: PMC3484379          DOI: 10.1016/j.humpath.2008.10.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.

Authors:  B L Baisden; H Kahane; J I Epstein
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

2.  Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists.

Authors:  Lars Egevad; William C Allsbrook; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2006-03       Impact factor: 3.466

Review 3.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue.

Authors:  P A Humphrey
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

4.  Prostatic adenocarcinoma with glomeruloid features.

Authors:  A Pacelli; A Lopez-Beltran; A J Egan; D G Bostwick
Journal:  Hum Pathol       Date:  1998-05       Impact factor: 3.466

5.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

6.  Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up.

Authors:  P Thorson; R T Vollmer; C Arcangeli; D W Keetch; P A Humphrey
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

7.  Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Adv Anat Pathol       Date:  2006-01       Impact factor: 3.875

8.  Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology.

Authors:  Mathieu Latour; Mahul B Amin; Athanase Billis; Lars Egevad; David J Grignon; Peter A Humphrey; Victor E Reuter; Wael A Sakr; John R Srigley; Thomas M Wheeler; Ximing J Yang; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

  8 in total
  19 in total

1.  [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Authors:  G Kristiansen; L Egevad; M Amin; B Delahunt; J R Srigley; P A Humphrey; J I Epstein
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

2.  Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Authors:  Hillary M Ross; Oleksandr N Kryvenko; Janet E Cowan; Jeffry P Simko; Thomas M Wheeler; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

3.  Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

Authors:  Charlotte F Kweldam; Mark F Wildhagen; Ewout W Steyerberg; Chris H Bangma; Theodorus H van der Kwast; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

Review 4.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

5.  Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

Authors:  Kenneth A Iczkowski; Kathleen C Torkko; Gregory R Kotnis; R Storey Wilson; Wei Huang; Thomas M Wheeler; Andrea M Abeyta; Francisco G La Rosa; Shelly Cook; Priya N Werahera; M Scott Lucia
Journal:  Am J Clin Pathol       Date:  2011-07       Impact factor: 2.493

6.  TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

Authors:  Samson W Fine; Anuradha Gopalan; Margaret A Leversha; Hikmat A Al-Ahmadie; Satish K Tickoo; Qin Zhou; Jaya M Satagopan; Peter T Scardino; William L Gerald; Victor E Reuter
Journal:  Mod Pathol       Date:  2010-06-18       Impact factor: 7.842

Review 7.  Clinical implications of changing definitions within the Gleason grading system.

Authors:  Tamara L Lotan; Jonathan I Epstein
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

8.  Histopathological Study of the Prostate Cancer Growth Patterns in Relation with the Grading Systems.

Authors:  Tudor Cristian Timotei Popescu; Alex Emilian Stepan; Mirela Marinela Florescu; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2022-03-31

9.  Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

Authors:  Jianfeng Xu; Siqun Lilly Zheng; Sarah D Isaacs; Kathleen E Wiley; Fredrik Wiklund; Jielin Sun; A Karim Kader; Ge Li; Lina D Purcell; Seong-Tae Kim; Fang-Chi Hsu; Pär Stattin; Jonas Hugosson; Jan Adolfsson; Patrick C Walsh; Jeffrey M Trent; David Duggan; John Carpten; Henrik Grönberg; William B Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

Review 10.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.